Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Diffuse large B-cell lymphoma recurrent
ADR ID BADD_A07154
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.02      Diffuse large B-cell lymphomas
01.15.02.002      Diffuse large B-cell lymphoma recurrent
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.02      Diffuse large B-cell lymphomas
16.28.02.002      Diffuse large B-cell lymphoma recurrent
Description Not Available
MedDRA Code 10012821
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
B-immunoblastic lymphoma (Kiel Classification) recurrent | B-large cell anaplastic Lymphoma (Kiel Classification) recurrent | Centroblastic lymphoma recurrent | Diffuse large B-cell lymphoma recurrent | Diffuse large cell cleaved lymphoma (Working Formulation) recurrent | Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) recurrent | Diffuse mixed small and large cell lymphoma (Diffuse large B-cell lymphoma) recurrent | Large cell immunoblastic lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) recurrent | Reticulosarcoma recurrent
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00230Bendamustine0.000336%
BADD_D00723Doxorubicin0.000112%
BADD_D00914Fludarabine0.000112%
BADD_D01253Lenalidomide0.001953%
BADD_D01933Ribavirin0.005934%
The 1th Page    1    Total 1 Pages